Tanja Limberger

This study establishes a murine tumoroid biobank to identify oncogenic pathways and drug vulnerabilities in prostate cancer, finding that PTEN loss drives cancer pathways and that specific compounds inhibit tumor growth.

This study demonstrates the use of O-PTIR spectroscopy for label-free detection of micro- and nanoparticles in tissues, showing superior resolution and signal quality compared to FTIR.

This study shows that activating GP130 in prostate epithelial cells suppresses tumor growth through senescence and immune activation, suggesting a new therapeutic approach.